Literature DB >> 21361217

Dosimetry revisited for the HDR 192Ir brachytherapy source model mHDR-v2.

Domingo Granero1, Javier Vijande, Facundo Ballester, Mark J Rivard.   

Abstract

PURPOSE: Recently, the manufacturer of the HDR 192Ir mHDR-v2 brachytherapy source reported small design changes (referred to herein as mHDR-v2r) that are within the manufacturing tolerances but may alter the existing dosimetric data for this source. This study aimed to (1) check whether these changes affect the existing dosimetric data published for this source; (2) obtain new dosimetric data in close proximity to the source, including the contributions from 192Ir electrons and considering the absence of electronic equilibrium; and (3) obtain scatter dose components for collapsed cone treatment planning system implementation.
METHODS: Three different Monte Carlo (MC) radiation transport codes were used: MCNP5, PENELOPE2008, and GEANT4. The source was centrally positioned in a 40 cm radius water phantom. Absorbed dose and collision kerma were obtained using 0.1 mm (0.5 mm) thick voxels to provide high-resolution dosimetry near (far from) the source. Dose-rate distributions obtained with the three MC codes were compared.
RESULTS: Simulations of mHDR-v2 and mHDR-v2r designs performed with three radiation transport codes showed agreement typically within 0.2% for r > or = 0.25 cm. Dosimetric contributions from source electrons were significant for r < 0.25 cm. The dose-rate constant and radial dose function were similar to those from previous MC studies of the mHDR-v2 design. The 2D anisotropy function also coincided with that of the mHDR-v2 design for r > or = 0.25 cm. Detailed results of dose distributions and scatter components are presented for the modified source design.
CONCLUSIONS: Comparison of these results to prior MC studies showed agreement typically within 0.5% for r > or = 0.25 cm. If dosimetric data for r < 0.25 cm are not needed, dosimetric results from the prior MC studies will be adequate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21361217     DOI: 10.1118/1.3531973

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  16 in total

1.  Inorganic scintillation detectors based on Eu-activated phosphors for 192Ir brachytherapy.

Authors:  Gustavo Kertzscher; Sam Beddar
Journal:  Phys Med Biol       Date:  2017-05-05       Impact factor: 3.609

2.  A detailed Monte Carlo evaluation of 192Ir dose enhancement for gold nanoparticles and comparison with experimentally measured dose enhancements.

Authors:  Tara Gray; Nema Bassiri; Shaquan David; Devanshi Yogeshkumar Patel; Sotirios Stathakis; Neil Kirby; Kathryn M Mayer
Journal:  Phys Med Biol       Date:  2020-07-06       Impact factor: 3.609

3.  Therapeutic analysis of high-dose-rate (192)Ir vaginal cuff brachytherapy for endometrial cancer using a cylindrical target volume model and varied cancer cell distributions.

Authors:  Hualin Zhang; Eric D Donnelly; Jonathan B Strauss; Yujin Qi
Journal:  Med Phys       Date:  2016-01       Impact factor: 4.071

4.  Dosimetric investigation of a new high dose rate 192Ir brachytherapy source, IRAsource, by Monte Carlo method.

Authors:  Atefeh Rostami; Mahdi Hoseini; Mahdi Ghorbani; Courtney Knaup
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-26

5.  Film based verification of calculation algorithms used for brachytherapy planning-getting ready for upcoming challenges of MBDCA.

Authors:  Grzegorz Zwierzchowski; Grzegorz Bielęda; Janusz Skowronek; Magdalena Mazur
Journal:  J Contemp Brachytherapy       Date:  2016-08-16

6.  Revision of the dosimetric parameters of the CSM11 LDR Cs-137 source.

Authors:  Antonio Otal; Juan Manuel Martínez-Fernández; Domingo Granero
Journal:  J Contemp Brachytherapy       Date:  2011-03-31

7.  Monte Carlo dosimetric study of the Flexisource Co-60 high dose rate source.

Authors:  Javier Vijande; Domingo Granero; Jose Perez-Calatayud; Facundo Ballester
Journal:  J Contemp Brachytherapy       Date:  2012-03-30

8.  After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer.

Authors:  Satoshi Nakamura; Naoya Murakami; Koji Inaba; Akihisa Wakita; Kazuma Kobayashi; Kana Takahashi; Hiroyuki Okamoto; Rei Umezawa; Madoka Morota; Minako Sumi; Hiroshi Igaki; Yoshinori Ito; Jun Itami
Journal:  BMC Cancer       Date:  2016-05-03       Impact factor: 4.430

9.  Quality Assurance Procedures based on Dosimetric, Gamma Analysis as a Fast Reliable Tool for Commissioning Brachytherapy Treatment Planning Systems.

Authors:  Grzegorz Zwierzchowski; Grzegorz Bieleda; Janusz Skowronek
Journal:  Radiol Oncol       Date:  2017-11-29       Impact factor: 2.991

10.  Gafchromic film dosimetry of a new HDR 192Ir brachytherapy source.

Authors:  Navid Ayoobian; Akbar Sarabi Asl; Hosein Poorbaygi; Mohammad Reza Javanshir
Journal:  J Appl Clin Med Phys       Date:  2016-03-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.